It will be critical for companies to be aware of external policies to find the right balance of criteria for re-entry into clinics & hospitals to ensure a safe and productive interaction for the benefit of Canadian patients.

Pangaea confirms the amendments to the Patented Medicines Regulations to take effect July 1, 2020, will be implemented January 1, 2021.

As the home office environment is new to many in this industry, we thought we would share some best practices for working virtually.

The PMPRB plans to publish revised draft Guidelines this spring, that will have only a limited time-frame for feedback before being finalized.

On March 25, Bill C-13, the COVID-19 Emergency Response Act, received Royal Assent that includes amendments to both the Patent Act and the Food and Drugs Act to ensure the availability of drugs and medical devices.

On Friday, March 13, the House of Commons and the Senate approved the new USMCA within hours of each other.

With the changing of demographics and shifting in attitudes, the onboarding process can never be a static situation and should be reviewed on an ongoing basis.

So where are we regarding timing before the flood gates open?

It has taken significant time to mend the relationship between pharmacy and the Ontario government since the 2010 pharmacy rallies at Queen’s Park in response to the elimination of professional allowances.

This was not a surprise as rumblings about Alberta taking the biosimilars plunge had been circulating for a few months.